Anavex Life Sciences Stock Is Deeply Oversold. Should You Buy the Dip?
Corroborated by 1 source from 1 publisher
globalbusiness1d ago
TL;DR
According to finance.yahoo.com, anavex Life Sciences (AVXL) stock crashed on March 25 after the company unexpectedly withdrew its marketing authorization application for blarcamesine in the European Union.